Lindsey Robert Baden
#122,358
Most Influential Person Now
Lindsey Robert Baden's AcademicInfluence.com Rankings
Lindsey Robert Badenphilosophy Degrees
Philosophy
#5588
World Rank
#8431
Historical Rank
Logic
#2840
World Rank
#3901
Historical Rank
Lindsey Robert Badenbiology Degrees
Biology
#7478
World Rank
#10410
Historical Rank
Immunology
#407
World Rank
#422
Historical Rank
Download Badge
Philosophy Biology
Lindsey Robert Baden's Degrees
- Doctorate Medicine Harvard University
Why Is Lindsey Robert Baden Influential?
(Suggest an Edit or Addition)Lindsey Robert Baden's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (2020) (5634)
- Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. (2001) (1006)
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 (2020) (993)
- Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. (2004) (865)
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host (2020) (784)
- SARS-CoV-2 viral load is associated with increased disease severity and mortality (2020) (576)
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial (2021) (501)
- Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. (2010) (403)
- Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. (2004) (402)
- Prevention and treatment of cancer-related infections. (2012) (369)
- Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. (2008) (355)
- Covid-19 — The Search for Effective Therapy (2020) (299)
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology (2015) (286)
- Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase (2021) (278)
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. (2011) (257)
- Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. (2006) (252)
- Enterovirus 71 infections and neurologic disease--United States, 1977-1991. (1994) (245)
- Heart and Lung Transplants from HCV‐Infected Donors to Uninfected Recipients (2019) (216)
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) (2018) (214)
- Prevention and treatment of cancer-related infections, version 2.2016 (2016) (214)
- Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease. (2009) (209)
- SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination (2022) (202)
- Post-transplant acute limbic encephalitis (2007) (202)
- Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis (2006) (202)
- Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. (2003) (184)
- Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (2020) (184)
- Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies (2015) (179)
- Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. (2013) (169)
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19 (2022) (165)
- Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. (2011) (162)
- Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. (2001) (156)
- First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). (2013) (155)
- Molecular Methods To Improve Diagnosis and Identification of Mucormycosis (2011) (152)
- Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. (2021) (148)
- A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204) (2011) (148)
- Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial (2021) (144)
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1 (2020) (143)
- Viral disease prevention after hematopoietic cell transplantation (2009) (142)
- Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. (2012) (138)
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1 (2021) (134)
- Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. (2013) (133)
- Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. (2007) (133)
- Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. (2009) (129)
- Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. (2012) (127)
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3 (2021) (120)
- Reactivity of (1→3)-β-d-Glucan Assay with Commonly Used Intravenous Antimicrobials (2006) (116)
- Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120: Negative Results Fail to Trigger a Phase 3 Correlates Trial (2007) (115)
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 (2022) (112)
- Humoral signatures of protective and pathological SARS-CoV-2 infection in children (2021) (110)
- A breath fungal secondary metabolite signature to diagnose invasive aspergillosis. (2014) (110)
- Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination (2016) (109)
- Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). (2013) (109)
- Ebola and quarantine. (2014) (108)
- Non‐tuberculous mycobacterial infection among lung transplant recipients: a 15‐year cohort study (2012) (103)
- Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients. (2007) (102)
- (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. (2007) (101)
- Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. (2007) (100)
- Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. (2005) (99)
- Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. (2016) (99)
- Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults (2012) (98)
- Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup (2021) (98)
- Medical Journals and the 2019-nCoV Outbreak. (2020) (96)
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial (2017) (96)
- Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation. (2006) (94)
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3 (2020) (82)
- Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis (2010) (82)
- Infectious complications associated with immunomodulating biologic agents. (2010) (81)
- Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials. (2006) (80)
- Risks Associated With Lentiviral Vector Exposures and Prevention Strategies (2016) (78)
- Zika Virus and Microcephaly. (2016) (78)
- Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. (2014) (77)
- Quinolones and false-positive urine screening for opiates by immunoassay technology. (2001) (77)
- Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study (2007) (75)
- Fungal brain infections (2008) (75)
- Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole1 (2003) (71)
- Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients (2021) (70)
- Fungal Infections of the CNS (2007) (70)
- Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy (2003) (69)
- SARS-CoV-2-specific ELISA development (2020) (68)
- Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis. (2010) (67)
- Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. (2011) (67)
- High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. (2005) (67)
- Preexposure prophylaxis for HIV--where do we go from here? (2012) (66)
- Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. (2016) (66)
- Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods (2012) (66)
- Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans. (2015) (65)
- Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization (2016) (65)
- Prevention and treatment of cancer-related infections. (2012) (63)
- Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract. (2006) (63)
- Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization (2009) (63)
- Prophylactic antimicrobial agents and the importance of fitness. (2005) (62)
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2 (2020) (62)
- Cord colitis syndrome in cord-blood stem-cell transplantation. (2011) (62)
- Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. (2010) (62)
- Invasive fungal disease in patients treated for newly diagnosed acute leukemia (2010) (62)
- Selective Lymphopenia and Opportunistic Infections in Neuroendocrine Tumor Patients Receiving Temozolomide (2007) (60)
- Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia. (2012) (60)
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2 (2021) (59)
- BK virus disease after allogeneic stem cell transplantation: a cohort analysis. (2014) (59)
- H1N1 influenza A disease--information for health professionals. (2009) (57)
- B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV (2021) (57)
- Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain (2021) (55)
- Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults. (2008) (53)
- Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. (2014) (52)
- Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States (2014) (52)
- Disseminated Trichosporonosis Caused by Trichosporon loubieri (2003) (49)
- Human papillomavirus vaccine--opportunity and challenge. (2007) (49)
- Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients (2021) (46)
- Ebola--an ongoing crisis. (2014) (46)
- Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial (2011) (44)
- Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. (2013) (44)
- Infections Following Facial Composite Tissue Allotransplantation—Single Center Experience and Review of the Literature (2013) (44)
- Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients. (2010) (43)
- Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study (2019) (42)
- The Urgency of Care during the Covid-19 Pandemic — Learning as We Go (2020) (42)
- Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009 (2011) (42)
- Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good. (2022) (39)
- The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus. (2003) (39)
- A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation: A Sequential Cohort Analysis (2012) (38)
- When to start antiretroviral therapy--ready when you are? (2009) (38)
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4 (2022) (38)
- Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system (2022) (37)
- Pneumonia in the immunocompromised host (2014) (35)
- An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice (2021) (34)
- Management of oral infections in cancer patients. (2008) (33)
- Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients (2020) (33)
- Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. (2013) (32)
- Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. (2010) (30)
- Risk factors for invasive fungal disease in heart transplant recipients. (2015) (30)
- Clinical decisions. Management of skin and soft-tissue infection--polling results. (2008) (30)
- Human herpesvirus 6 encephalitis (2008) (29)
- Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors (2015) (29)
- First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector (2018) (29)
- Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection (2022) (29)
- Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. (2012) (28)
- Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge (2021) (28)
- Reply to Commentary on the ACR "COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases". (2021) (28)
- Fever and neutropenia clinical practice guidelines. (2004) (27)
- Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection (2020) (26)
- Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (2017) (26)
- First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). (2014) (26)
- Diagnosis and management of Enterococcus spp infections during rehabilitation of cold-stunned Kemp's ridley turtles (Lepidochelys kempii): 50 cases (2006-2012). (2014) (26)
- Audio Interview: New Research on Possible Treatments for Covid-19. (2020) (26)
- Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19 (2020) (26)
- Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study (2020) (25)
- Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis (2013) (25)
- Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial (2022) (25)
- Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens (2021) (24)
- Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial (2022) (24)
- The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays. (2009) (24)
- Q fever endocarditis associated with extensive serological cross-reactivity. (2000) (24)
- Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. (2011) (24)
- Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. (2016) (23)
- Development and Evaluation of a Calibrator Material for Nucleic Acid-Based Assays for Diagnosing Aspergillosis (2013) (23)
- Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation (2018) (22)
- Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. (2009) (22)
- Antibacterial prophylaxis in patients with cancer and neutropenia. (2006) (21)
- Risk of Latent Tuberculosis Reactivation after Hematopoietic-Cell Transplantation. (2019) (21)
- A Large, Simple Trial Leading to Complex Questions (2020) (21)
- Epstein-Barr and other herpesvirus infections in patients with early onset type 1 diabetes treated with daclizumab and mycophenolate mofetil. (2013) (20)
- Antibiotic prophylaxis for patients with acute leukemia (2008) (20)
- Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. (2015) (20)
- Getting smarter--the toxicity of undertreated HIV infection. (2006) (20)
- Current practice of HIV postexposure prophylaxis treatment for sexual assault patients in an emergency department. (2014) (19)
- Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens (2015) (19)
- Needed: Antimicrobial Development. (2019) (18)
- Infectious complications associated with immunomodulating monoclonal antibodies used in the treatment of hematologic malignancy. (2008) (18)
- Vaccination after stem cell transplant: a review of recent developments and implications for current practice (2008) (18)
- The road to an effective HIV vaccine. (2012) (18)
- Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia (2007) (18)
- Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies (2021) (17)
- Out of Africa--caring for patients with Ebola. (2014) (17)
- Ebola in West Africa at one year--from ignorance to fear to roadblocks. (2015) (17)
- Long-Term Stability at −20°C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens (2014) (17)
- Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation (2017) (17)
- Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination (2021) (16)
- Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial (2021) (16)
- Breath-Based Diagnosis of Invasive Mucormycosis (IM) (2017) (15)
- Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. (2013) (14)
- Increasing access to thoracic organs from donors infected with hepatitis C: A previous challenge-now an opportunity. (2017) (14)
- Plateletpheresis-associated lymphopenia in frequent platelet donors. (2019) (14)
- We Can Do Better - Improving Outcomes in the Midst of an Emergency. (2017) (14)
- Case records of the Massachusetts General Hospital. Weekly Clinicopathological exercises. Case 4-2003. A 42-year-old woman with cough, fever, and abnormalities on thoracoabdominal computed tomography. (2003) (14)
- Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System (2022) (14)
- Current issues in vaccines for adult patients with hematologic malignancies. (2012) (14)
- Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes (2021) (13)
- Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. (2012) (13)
- SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses (2022) (13)
- Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials (2020) (13)
- Infectious complications associated with immunomodulating biologic agents. (2011) (13)
- Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019 (2021) (12)
- Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study (2021) (12)
- Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib (2018) (12)
- Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination (2016) (12)
- Heerfordt's Syndrome, or Uveoparotid Fever (2013) (12)
- Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial (2019) (11)
- An Algorithmic Computerised Order Entry Approach to Assist in the Prescribing of New Therapeutic Agents (2004) (11)
- A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated (2021) (11)
- Chest Pain with a Surprising Course (1999) (10)
- Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation. (2021) (10)
- The FDA and the Importance of Trust. (2020) (10)
- Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial. (2016) (10)
- Prevention and therapy of fungal infections in bone marrow transplantation (2003) (10)
- Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19 (2020) (10)
- US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19 (2021) (10)
- Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (2021) (9)
- Integrative omics to detect bacteremia in patients with febrile neutropenia (2018) (9)
- Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune Disorders. (2015) (9)
- Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants (2014) (9)
- Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19. (2020) (9)
- Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity (2021) (9)
- Invasive fungal disease after remote inoculation in transplant recipients. (2011) (9)
- Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2 (2020) (8)
- Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel. (2021) (8)
- Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients. (2020) (8)
- Trigeminal trophic syndrome with features of oral CMV disease. (2008) (8)
- Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study (2020) (8)
- Audio Interview: India's Covid-19 Crisis. (2021) (8)
- Specialty and training differences in the reported use of endocarditis prophylaxis at an academic medical center. (2001) (8)
- Audio Interview: The Omicron Variant of SARS-CoV-2. (2021) (8)
- Genome‐wide association analysis of COVID‐19 mortality risk in SARS‐CoV‐2 genomes identifies mutation in the SARS‐CoV‐2 spike protein that colocalizes with P.1 of the Brazilian strain (2021) (7)
- Audio Interview: Approaches to Covid-19 Vaccines and Antivirals. (2020) (7)
- SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity (2021) (7)
- Evaluation of three commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2 (2021) (7)
- Gastrointestinal infections in the immunocompromised host. (2001) (7)
- Serologic Response to Hepatitis B Vaccination Among Lung Transplantation Candidates (2014) (7)
- Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis. (2019) (7)
- Case records of the Massachusetts General Hospital. Case 35-2009. A 60-year-old male renal-transplant recipient with renal insufficiency, diabetic ketoacidosis, and mental-status changes. (2009) (7)
- Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. (2018) (7)
- Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma (2020) (7)
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5 (2022) (7)
- Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies (2022) (7)
- Exploiting Viruses to Treat Diseases. (2018) (6)
- Clinical decisions. Management of incidental hepatitis C virus infection--polling results. (2009) (6)
- Compounding errors. (2012) (6)
- Viral Load Kinetics of SARS-CoV-2 In Hospitalized Individuals with COVID-19 (2021) (6)
- Serum Galactomannan and (1→3)-β-d-Glucan Assays for Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia (2011) (6)
- For an influenza vaccine, are two Bs better than one? (2013) (6)
- The sentinel chicken revisited: the impact of West Nile virus infection on transplant patients. (2004) (6)
- Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome (2022) (6)
- Expanding the Donor Pool With Use of Hepatitis C Infected Hearts. (2018) (6)
- Audio Interview: Practical Measures to Help Prevent Covid-19. (2020) (6)
- Pharmacokinetics of Ganciclovir Following Oral Valganciclovir Versus Intravenous Ganciclovir in Allogeneic Hematopoietic Stem-Cell Transplant Patients with Stable Graft-Versus-Host Disease of the Gastrointestinal Tract. (2004) (6)
- Prelaminated Free Flap for Auricular Reconstruction (2013) (6)
- Audio Interview: Understanding the Omicron Variant of SARS-CoV-2. (2022) (5)
- The Potential of Intentional Drug Development (2022) (5)
- Congenital Duodenal Obstruction and Double-Bubble Sign (2014) (5)
- Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection) (2021) (5)
- Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens (2021) (5)
- Transplanting Thoracic Organs from Hepatitis C Positive Donors to Hepatitis C Uninfected Recipients (2018) (5)
- Audio Interview: Loosening Covid-19 Restrictions. (2020) (5)
- Clinical characteristics and outcomes of clostridial bacteraemia in cancer patients (2014) (5)
- Clinical characteristics and outcomes of clostridial bacteraemia in cancer patients (2014) (5)
- The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients (2022) (5)
- Omicron — Decoupling Infection from Severe Disease (2022) (5)
- Abdominal-Wall Varices in the Budd-Chiari Syndrome (2014) (5)
- Impact of antibiotic resistance on the treatment of gram-negative sepsis (2000) (5)
- Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System (2022) (5)
- Infectious Disease Issues in the Well Transplant Patient (2001) (5)
- Opportunistic Infections (OIs) in Patients with Hematologic Malignancies (HM) Treated with Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study (2017) (5)
- Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies (2022) (4)
- Rectal and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. (2021) (4)
- Green Herring Syndrome: Bacterial Infection in Patients With Mucormycosis Cavitary Lung Disease (2014) (4)
- Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge (2021) (4)
- Audio Interview: A Covid-19 Conversation with Anthony Fauci. (2021) (4)
- Long-Term Stability at -20 degrees C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens (4)
- Audio Interview: Preparing for the Spread of Covid-19. (2020) (4)
- Adamantinomatous Craniopharyngioma Containing Teeth (2014) (4)
- Enterovirus Infection in Immunocompromised Hosts (2019) (4)
- Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant. (2021) (4)
- Acupuncture with Gold Thread for Osteoarthritis of the Knee (2013) (4)
- Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19. (2023) (4)
- Audio Interview: A New Monoclonal Antibody for Covid-19. (2020) (4)
- Hyperviscosity-Related Retinopathy in Waldenström's Macroglobulinemia (2016) (4)
- Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity (2021) (4)
- Congenital Sutural Cataract (2014) (4)
- Audio Interview: Emerging Tools in the Fight against Covid-19. (2020) (4)
- Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant. (2021) (3)
- Fever, Neutropenia, and the Second Law of Thermodynamics (2002) (3)
- Fever in a returned traveler: an "off the cuff" diagnosis. (2003) (3)
- Posaconazole for invasive aspergillosis? (2007) (3)
- Cystine Crystals in Bone Marrow (2015) (3)
- Hepatitis B virus screening and potential reactivation in patients undergoing treatment for cancer. (2014) (3)
- BK Virus Disease Following Allogeneic Stem Cell Transplantation: A Cohort Analysis (2012) (3)
- An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice (2021) (3)
- 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases (2023) (3)
- Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial (2022) (3)
- Clinical problem-solving. Chest pain with a surprising course. (1999) (3)
- Loss of Fingerprints (2015) (3)
- Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel (2021) (3)
- Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial (2022) (3)
- Reply to “Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan” (2014) (3)
- Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia. (2011) (3)
- Audio Interview: Caring for Patients with Covid-19. (2020) (3)
- Infection in the Hematopoietic Stem Cell Transplant Recipient (2008) (2)
- Infectious Complications Associated with Immunomodulating (2010) (2)
- Long-term colonization with vancomycin-resistant Enterococcus faecium (1998) (2)
- Risk of HHV6-Associated Post-Transplant Acute Limbic Encephalitis (PALE) after Umbilical Cord Blood Stem Cell Transplantation: A Cohort Analysis. (2006) (2)
- A Blinking Knee (2014) (2)
- Audio Interview: The Impact of Covid-19 on Minority Communities. (2020) (2)
- Audio Interview: Viral Variants and Covid-19. (2021) (2)
- The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. (2020) (2)
- Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations. (2020) (2)
- Frontal Sinusitis Causing Epidural Abscess and Puffy Tumor (2014) (2)
- transplantation: a cohort analysis cytomegalovirus reactivation after allogeneic hematopoietic stem cell Sirolimus-based graft-versus-host disease prophylaxis protects against (2011) (2)
- Cullen's and Grey Turner's Signs in Acute Pancreatitis (2015) (2)
- Audio Interview: Lessons from Covid-19 Hotspots. (2020) (2)
- Prolonged Antibiotic Prophylaxis after Left Ventricular-Assist Device (LVAD) Implantation is Associated with Increased Antibacterial Resistance (2015) (2)
- 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases (2023) (2)
- Audio Interview: A Covid-19-Related Syndrome in Children. (2020) (2)
- Audio Interview: The Challenges of Safe Reopening. (2020) (2)
- Audio Interview: Covid-19 Vaccine Fundamentals. (2020) (2)
- Audio Interview: Delivering Covid-19 Vaccines to Minority Communities. (2021) (2)
- Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials. (2022) (2)
- Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot. (2020) (2)
- Audio Interview: Dexamethasone and Covid-19. (2020) (2)
- Audio Interview: A Look at Covid-19 Prevention and Care in 2020. (2020) (2)
- Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions. (2021) (2)
- Risk of HHV6-Associated Post-Transplant Acute Limbic Encephalitis (PALE) after Umbilical Cord Blood Stem Cell Transplantation: A Cohort Analysis. (2006) (2)
- Audio Interview: The Impact of Covid-19 on Patients with Other Diseases, with Arnold Epstein. (2020) (2)
- Audio Interview: Studying Potential Covid-19 Therapies. (2020) (2)
- A new era for sepsis treatment? Understanding sepsis as a consequence of host immune response (2002) (1)
- Audio Interview: Waning Immunity against SARS-CoV-2. (2021) (1)
- Audio Interview: Assessing Vaccine Safety. (2021) (1)
- Audio Interview: Covid-19 and Contact Tracing. (2020) (1)
- Audio Interview: Acute Lung Injury in Covid-19. (2020) (1)
- Severe Vitamin D Deficiency — Rickets (2013) (1)
- 586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies (2021) (1)
- Lingual Squamous-Cell Carcinoma (2013) (1)
- Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children. (2021) (1)
- Dasatinib Use May Be a Novel Risk Factor for Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (2016) (1)
- Internal Carotid Artery in the Middle Ear (2014) (1)
- Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies. (2022) (1)
- AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period. (2021) (1)
- Adult Vaccination Schedule after Solid Organ Transplant (2011) (1)
- 132 – Vaccines for Human Immunodeficiency Virus Type 1 Infection (2015) (1)
- Safety and Immunogenicity of Modi fi ed Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients : A Randomized , Controlled Trial (2013) (1)
- The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes. (2020) (1)
- Orofacial Fistulae Associated with Crohn's Disease (2015) (1)
- Cutaneous Leishmaniasis with a Paronychia-like Lesion (2014) (1)
- RELATIONSHIPS BETWEEN MYOCARDIAL INJURY, INDEX HOSPITALIZATION CHARACTERISTICS, AND LONGER-TERM OUTCOMES IN SARS-COV-2 INFECTION (2021) (1)
- Audio Interview: Antibody Responses to Natural Infection and Vaccination. (2021) (1)
- Vaccines for Human Immunodeficiency Virus-1 Infection (2010) (1)
- Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout. (2021) (1)
- Audio Interview: What Earlier Epidemics Teach Us about Covid-19. (2021) (1)
- Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination. (2021) (1)
- Audio Interview: Looking Back and Looking Forward - Part 2. (2021) (1)
- Unsupervised genome-wide cluster analysis: nucleotide sequences of the omicron variant of SARS-CoV-2 are similar to sequences from early 2020 (2021) (1)
- Audio Interview: Vaccine Efficacy and Boosters in Covid-19. (2021) (1)
- Audio Interview: Protecting the Immunocompromised from Covid-19. (2022) (1)
- Audio Interview: Studying Long Covid. (2022) (1)
- Audio Interview: Guidelines for Covid-19 Vaccine Deployment. (2020) (1)
- Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. (2023) (1)
- Subperiosteal Bone Resorption (2014) (1)
- Is ex-vivo viral eradication possible? (2020) (1)
- Successful treatment of angioinvasive aspergillosis during prolonged neutropenia with liposomal amphotericin, voriconazole, and caspofungin (2002) (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients (2023) (1)
- Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation (2023) (1)
- Long-Term Outcomes in Heart and Lung Transplants from HCV-Viremic Donors to Uninfected Recipients: The Donate HCV Trial (2021) (1)
- Audio Interview: Aspects of Covid-19 Immunity. (2021) (1)
- Audio Interview: An International Look at Covid-19. (2021) (1)
- Squamous-Cell Carcinoma of the Penis with Human Papillomavirus (2016) (1)
- JAMA Peer Reviewers in 2020. (2021) (1)
- On the "Take" as a Biomarker. (2019) (1)
- Heterotopic Ossification of a Midline Abdominal Incision (2014) (1)
- Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial (2021) (1)
- Audio Interview: Vaccinating Children. (2021) (1)
- Audio Interview: Covid-19: Why We Publish What We Do. (2022) (1)
- Audio Interview: Potential Covid Vaccine Strategies. (2022) (1)
- Interactive medical case. A man with fever, cough, and rash. (2014) (1)
- Audio Interview: Responding to Monkeypox. (2022) (1)
- Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty. (2021) (1)
- Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords (2021) (1)
- Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis (2010) (1)
- Discharging Dental Sinus Tract (2014) (1)
- Invasive Yeast Infection After Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome. (2022) (1)
- Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials? (2021) (1)
- Occipital Calcification and Celiac Disease (2014) (1)
- Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial (2023) (0)
- Audio Interview: The Future of Covid-19 Research. (2023) (0)
- Audio Interview: Treating Complications of Covid Vaccination. (2021) (0)
- Transplant 101: Immunosuppression and Infection Risk (2009) (0)
- Audio Interview: Looking Back and Looking Forward. (2021) (0)
- An Unusual Auricular Foreign Body (2014) (0)
- Acute Neck Infection (2014) (0)
- Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study. (2022) (0)
- Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. (2023) (0)
- Sydenham's Chorea, or St. Vitus's Dance (2013) (0)
- Diagnosing Aspergillosis Material for Nucleic Acid-Based Assays for Development and Evaluation of a Calibrator (2014) (0)
- HHV-6-Associated Post-Transplantation Acute Limbic Encephalitis Following Cord Blood Stem Cell Transplantation: A Cohort Analysis (2011) (0)
- Anterior Dislocation of the Lens (2014) (0)
- Audio Interview: Effectiveness of Covid-19 Vaccination in Children. (2022) (0)
- Audio Interview: Reinventing the Research Infrastructure to Address Covid-19. (2022) (0)
- Audio Interview: Building a Successful Public Health Response to Covid-19. (2020) (0)
- Precision immunology for discovery and development of the Precision Vaccines Program (PVP)-037 small molecule series: imidazopyrimidine adjuvants identified via age-specific human in vitro modeling (2020) (0)
- Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults (2023) (0)
- Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees (2020) (0)
- Correspondence Posaconazole for Invasive Aspergillosis (2007) (0)
- In Vitro Volatile Metabolite Signatures of Common Pathogenic Fusarium Species (2016) (0)
- Langerhans'-Cell Histiocytosis (2014) (0)
- Audio Interview: An Update from Operation Warp Speed. (2020) (0)
- 1130. Low Risk of Pneumocystis jiroveci Pneumonia in Patients With Waldenstrom’s Macroglobulinemia on Ibrutinib (2018) (0)
- Audio Interview: A Look at SARS-CoV-2 Transmission. (2020) (0)
- Audio Interview: What the U.S. Response to Covid-19 Looks Like Today. (2020) (0)
- Audio Interview: Covid-19 Vaccines and the FDA. (2022) (0)
- Heart and Lung Transplants from HCV-Infected Donors. Reply. (2019) (0)
- 24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients (2021) (0)
- Audio Interview: A New mRNA Vaccine. (2021) (0)
- Ventricular Fibrillation during Left Ventriculography (2014) (0)
- Audio Interview: Covid-19 Takeaways at Podcast 100. (2022) (0)
- Audio Interview: Covid-19 and Health Equity. (2022) (0)
- Audio Interview: Operation Warp Speed and Covid-19. (2020) (0)
- Prevention and Treatment of Cancer-Related InfectionsPractice Guidelines in Oncology (2012) (0)
- Mechanical Small-Bowel Obstruction (2014) (0)
- Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates. (2021) (0)
- Bilateral Corneal Perforation (2014) (0)
- Squamous-Cell Carcinoma of the Nail Bed (2015) (0)
- LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19 (2022) (0)
- 87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up (2019) (0)
- Adult Vaccination Schedule after Allogeneic Stem Cell Transplant (2011) (0)
- Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic? (2021) (0)
- Tongue Fasciculations in Amyotrophic Lateral Sclerosis (2014) (0)
- Audio Interview: Combating Covid-19 Today and Tomorrow. (2022) (0)
- The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients (2022) (0)
- Cervical Aortic Arch (2014) (0)
- Audio Interview: Communicating Covid-19 Science. (2022) (0)
- Evolving Infarction in the Anterior Circulation (2014) (0)
- Superior Vena Cava Syndrome (2014) (0)
- Ocular Manifestation of Electrical Burn (2014) (0)
- Isolated Uvular Angioedema (2014) (0)
- West Nile Virus in Immunocompromised Hosts (2019) (0)
- Femoral-Head Dislocation to the Scrotum (2015) (0)
- Audio Interview: Ending the Covid-19 Public Health Emergency. (2023) (0)
- Zosteriform Metastases from Malignant Melanoma (2014) (0)
- Audio Interview: Capitalizing on Immune Responses to Covid-19. (2020) (0)
- Audio Interview: Monoclonal Antibodies and Booster Shots. (2021) (0)
- Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. (2023) (0)
- Audio Interview: The Expanding Arsenal of Oral Agents to Treat Covid-19. (2023) (0)
- Audio Interview: What to Make of Covid-19 Hot Spots. (2022) (0)
- Audio Interview: Tocilizumab and Covid-19. (2020) (0)
- Audio Interview: Choosing an Antiviral to Treat Covid-19. (2022) (0)
- Hidden in plain sight: urinary Cryptococcus neoformans missed by routine diagnostics in a patient with acute leukemia (2022) (0)
- Audio Interview: Covid-19 in Europe and New Information on Vaccines. (2020) (0)
- Audio Interview: Eight Months of Action and Inaction against Covid-19. (2020) (0)
- Audio Interview: When to Get a Second Covid-19 Booster Shot. (2023) (0)
- Audio Interview: Can Vaccines Prevent Transmission of Covid-19? (2022) (0)
- Audio Interview: Rolling Out New Covid-19 Vaccines. (2022) (0)
- Norovirus Infection in Transplantation: Prolonged and Morbid Diarrhea (2016) (0)
- End of a Declared Public Health Emergency - Implications for U.S. Emergency Use Authorizations. (2023) (0)
- Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly. (2022) (0)
- Combination Antifungal Treatment for Mold Infections: Cons (2017) (0)
- Audio Interview: Diagnosis and Early Treatment of Covid-19. (2020) (0)
- Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam. (2021) (0)
- Cerebrospinal Fluid Otorhinorrhea (2013) (0)
- Audio Interview: Do We Need a Fourth Dose of Covid Vaccine? (2022) (0)
- Impact of Changing Transplantation Practices and Conditioning Regimens on the Epidemiology of Transplant Related Infections: Stem Cell Transplantation (2004) (0)
- Cold Hands Associated with Scleroderma (2013) (0)
- Fatal COVID-19 is Characterized by Distinct Vasculopathic Features and Increased Congestion of the Alveolar Capillary-Bed (2021) (0)
- Bacterial and Fungal Infections in Hematopoietic Stem Cell Transplantation Recipients (2020) (0)
- Thanks to Reviewers—2020 (2020) (0)
- Audio Interview: A New Antiviral against Covid-19. (2022) (0)
- Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children. (2021) (0)
- Audio Interview: Weighing the Protective Value of Covid-19 Infection. (2023) (0)
- Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility (2023) (0)
- Audio Interview: Are Covid-19 Vaccine Boosters Necessary? (2021) (0)
- Audio Interview: New Studies of Covid-19 Transmission. (2020) (0)
- Audio Interview: Making Choices about Covid-19. (2022) (0)
- 2123. The Impact of Staphylococcus aureus Peri-transplant Cultures on Six-Month Outcomes in Lung Transplantation (2022) (0)
- Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide? (2021) (0)
- Audio Interview: Designing the Next Covid-19 Vaccine. (2022) (0)
- Audio Interview: Dissecting the Host Response to SARS-CoV-2. (2022) (0)
- Bacillus Cereus: A Leukemia-Specific, Neuroinvasive Pathogen? (2014) (0)
- Linear IgA Bullous Disease (2014) (0)
- Adenovirus Infections in Patients Undergoing Umbilical Cord Blood Hematopoietic Stem Cell Transplantation. (2009) (0)
- Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2. (2021) (0)
- Functional analyses and single cell immunoprofiling uncover sex-specific differences in SARS-CoV2 immune memory development (2022) (0)
- Contributors (2015) (0)
- The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human elders in vitro and aged mice in vivo (2022) (0)
- allogeneic hematopoietic stem cell transplant recipients: a cohort study invasive fungal infections in -Candida other emerging risk factors of non Infliximab use in patients with severe graft-versus-host disease and (2011) (0)
- Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice (2023) (0)
- Cutaneous and Gastrointestinal Purpura (2013) (0)
- Audio Interview: The Path Forward for Covid-19 Therapeutics. (2023) (0)
- Audio Interview: What to Expect from Covid-19 Vaccines. (2023) (0)
- Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice (2023) (0)
- Porphyria Cutanea Tarda and Hypertrichosis (2013) (0)
- Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky. (2021) (0)
- Polio: Nearing the Endgame (2007) (0)
- Audio Interview: Understanding Antibody Testing in Covid-19. (2020) (0)
- Audio Interview: Operation Warp Speed and Covid-19 Therapeutics. (2020) (0)
- Audio Interview: Another New Covid-19 Vaccine. (2021) (0)
- Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial (2022) (0)
- Audio Interview: A New Round of Rising Covid-19 Numbers. (2021) (0)
- Audio Interview: Covid-19: Where Are We Heading? (2022) (0)
- Decreasing incidence of candidemia without routine systemic antifungal prophylaxis (2015) (0)
- Audio Interview: Vaccination and Variants in the U.S. and South Africa. (2021) (0)
- Familial Multiple Lipomatosis (2014) (0)
- Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection. (2022) (0)
- Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment. (2021) (0)
- Monoclonal Antibodies and Vaccine Boosts. (2021) (0)
- Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest (2022) (0)
- Audio Interview: Covid-19 Vaccination and the Omicron Variant. (2021) (0)
- Herpes Zoster Involving the S1 Dermatome (2014) (0)
- 996. CD4+ T-Cell Lymphopenia Associated with Frequent Plateletpheresis in Healthy Donors (2021) (0)
- Audio Interview: Covid-19 as an Endemic Disease. (2022) (0)
- Traumatic Tension Pneumothorax Causing Heart Rotation (2014) (0)
- Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia. (2016) (0)
- Audio Interview: Caring for Hospitalized Patients with Covid-19. (2020) (0)
- Audio Interview: Making Covid-19 Vaccines Available around the World. (2022) (0)
- Safety and Immunogenicity of Modi fi ed Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial (2013) (0)
- Audio Interview: Infectious Disease in Africa. (2022) (0)
- Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters. (2021) (0)
- Audio Interview: Vaccinology and Covid-19. (2020) (0)
- Post-Study Point-of-Care Oral Fluid Testing in HIV-1 Vaccinees (2020) (0)
- Audio Interview: Developing New Covid-19 Vaccines. (2022) (0)
- The Impact of Left Ventricular Assist Device Infections on Clinical Outcomes (2022) (0)
- Audio Interview: Covid-19 Testing and the Individual Physician. (2020) (0)
- 94. Infectious Complications of Left Ventricular Assist Devices (2021) (0)
- Adenovirus Infection Following Hematopoietic Cell Transplantation (HCT) with Post-Transplant Cyclophosphamide (PTCy): Outcomes in Haploidentical Versus Matched or Mismatched Unrelated Donor (MUD/ MMURD) Allografts (2023) (0)
- Audio Interview: Do the Tobacco Wars Offer Any Lessons for the Vaccine Wars? (2022) (0)
- Audio Interview: A Look at the U.S. Government's Covid-19 Strategy. (2022) (0)
- Diagnostic TR-FRET assays for detection of antibodies in patient samples (2023) (0)
- Pulsatile Chest Swelling (2013) (0)
- Comparison of Clinical Characteristics and Outcomes between Candidemic Patients with Positive and Negative beta-D-Glucan (2015) (0)
- 1548. Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients (2018) (0)
- Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses. (2021) (0)
- An Unusual Tophus (2015) (0)
- 1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients (2018) (0)
- Audio Interview: Protecting the Immunosuppressed against Covid-19. (2021) (0)
- Audio Interview: A New Look at Covid-19 Vaccine Boosters. (2021) (0)
- Audio Interview: Covid-19 in Children. (2021) (0)
- Audio Interview: The Effects of Covid-19 on Children. (2022) (0)
- Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research. (2021) (0)
- Darwinian competition and the pathogenesis of opportunistic infection in the transplant recipient * (2005) (0)
- Audio Interview: Covid-19 and the WHO. (2022) (0)
- Audio Interview: Covid-19 - The Outlook in Europe. (2022) (0)
- Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial (2023) (0)
- 100. Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant (2021) (0)
- Audio Interview: Caring for Hospitalized Patients with Covid-19. (2022) (0)
- Safety of MMR Vaccination in Multiple Myeloma Patients Receiving Maintenance Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation. (2016) (0)
- Audio Interview: Vaccinating Young Children against Covid-19. (2022) (0)
- Safety of Live-attenuated Zoster Vaccination in Multiple Myeloma Patients Receiving Maintenance Lenalidomide after Autologous Stem Cell Transplantation. (2016) (0)
- Sequence-Based Discovery of Novel Bacteria, Bradyrhizobium Enterica, in Cord Colitis Syndrome (2013) (0)
- Audio Interview: The FDA and Covid-19 Vaccines. (2022) (0)
- Audio Interview: Assessing Bivalent Vaccines against Covid-19. (2022) (0)
- Audio Interview: Vaccine Successes and Vaccine Adverse Events. (2021) (0)
- Audio Interview: How Effective is Covid-19 Vaccination in Children? (2022) (0)
- Audio Interview: New Data on Remdesivir in Covid-19. (2020) (0)
- 36. Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation (2020) (0)
- Audio Interview: Finding Reliable Information about Covid-19. (2020) (0)
- Audio Interview: Five Disease Outbreaks beyond Covid-19. (2022) (0)
- Adenovirus (ADV) Infection and Disease after Allogeneic Hematopoetic Stem Cell Transplantation (HSCT): Epidemiology and Predictors of Mortality (2016) (0)
- Audio Interview: Can We Make More Effective Covid-19 Vaccines? (2022) (0)
- 25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients (2021) (0)
- Lindsay's Nails in Chronic Kidney Disease (2015) (0)
- Audio Interview: A Potential New Agent to Treat Covid-19. (2021) (0)
- 437 Safety and efficacy of immune checkpoint inhibitors (ICI) in patients living with HIV (PLWH) and metastatic non-small cell lung cancer (NSCLC): a matched cohort study from the international CATCH-IT consortium (2022) (0)
- Audio Interview: Developing Mucosal Immunity to Covid-19. (2022) (0)
- Cord Colitis: An Antibiotic-Responsive Colitis Syndrome Following Cord Blood Stem Cell Transplantation (2010) (0)
- Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization (cid:1) (2009) (0)
- Audio Interview: Covid-19 and the President. (2020) (0)
- Audio Interview: Covid-19 and the Media. (2021) (0)
- Audio Interview: Applying New Studies of Mpox and Ebola to Covid-19. (2022) (0)
- A Child with Gross Hematuria (2015) (0)
- 1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT) (2022) (0)
- Malaria - Epidemiology, Treatment, and Prevention. (2023) (0)
- Audio Interview: Addressing the Omicron Variant of SARS-CoV-2. (2022) (0)
- Audio Interview: Forecasting the Future of Covid. (2022) (0)
- Audio Interview: Updating and Standardizing Covid-19 Vaccines. (2023) (0)
- Audio Interview: Waning Immunity against Covid-19. (2022) (0)
- Comparative Effectiveness Analysis Of CD34+Selected, T-Cell Depleted (TCD) HLA-Matched Sibling Grafts On Allogeneic Hematopoietic Cell Transplantation For Patients With Acute Myeloid Leukemia (AML) In Complete Remission (2010) (0)
- Examining the In Vitro Volatile Metabolite Profile of Pathogenic Scedosporium and Lomentospora Species (2016) (0)
- Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing? (2021) (0)
- COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic (2022) (0)
- Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic (2013) (0)
- Audio Interview: Crushing the Covid-19 Curve. (2022) (0)
- Audio Interview: Reporting on Covid-19. (2021) (0)
- 1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT) (2018) (0)
- Speci fi city and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modi fi ed Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles (2014) (0)
- Temporal Trends in Stem Cell Transplant and Hematologic Malignancy Patients with Mucormycosis, 2001-2014 (2015) (0)
- Audio Interview: How Well Are Covid-19 Vaccines Working? (2021) (0)
- Next-Generation Sequencing for the Identification of Transplantation-Associated Pathogens (2012) (0)
- Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox. (2022) (0)
- Audio Interview: Covid-19 Vaccine Development. (2020) (0)
- Audio Interview: Covid-19 Vaccines and New Viral Variants. (2023) (0)
- Audio Interview: Masking and Covid-19. (2022) (0)
- An Avid Imitator (2016) (0)
- 209. Epstein-Barr Virus Surveillance in Lung Transplantation: Post-transplant Lymphoproliferative Disorder and Impact on Survival (2022) (0)
- Is the BCG Vaccine an Answer to Future Pandemic Preparedness? (2022) (0)
- Audio Interview: Preparing for the Next Pandemic. (2023) (0)
- Audio Interview: Protecting against Severe Disease and Transmission. (2021) (0)
- Audio Interview: Do We Need New Covid-19 Vaccines? (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lindsey Robert Baden?
Lindsey Robert Baden is affiliated with the following schools:
